← Back to Search

Depression Screening for Depression

N/A
Recruiting
Led By Sidney Hankerson, MD, MBA
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Currently receiving formal mental health treatment
Reporting active suicidality, or verbally endorsing homicidal ideation or psychotic symptoms
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 3- and 6-months post-screening
Awards & highlights

Summary

This trial will test whether screening for depression in black churches by Community Health Workers, with referral to treatment if necessary, is more effective than referral as usual in terms of treatment engagement.

Who is the study for?
This trial is for English-speaking adults over 18 in Black church communities who may be experiencing depression, as indicated by specific questionnaire scores. It's not open to those already in formal mental health treatment or individuals with active suicidal thoughts, homicidal ideation, or psychotic symptoms.
What is being tested?
The study compares two approaches: usual referral methods versus a more involved process called SBIRT (Screening, Brief Intervention, and Referral to Treatment) conducted by Community Health Workers. The effectiveness on engaging patients with depression treatments will be measured.
What are the potential side effects?
Since this trial involves screening and referrals rather than medication or medical procedures, there are no direct side effects from interventions like you might expect with drug trials.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently in treatment for a mental health condition.
Select...
I have not had thoughts of harming myself or others, nor experienced severe mental health symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 3- and 6-months post-screening
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 3- and 6-months post-screening for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Treatment Engagement
Secondary study objectives
Change in Anxiety Severity
Change in Depressive Severity
Change in Depressive Symptoms
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SBIRTExperimental Treatment1 Intervention
SBIRT will involve screening with the Patient Health Questionnaire-9 (PHQ-9); brief intervention with Motivational Interviewing (MI); and referral to specialty treatment, as needed for subjects with persistent depressive symptoms.
Group II: Referral As UsualActive Control1 Intervention
Referral as Usual will involve distributing depression educational materials (e.g., from the National Institute of Mental Health) and contact information for treatment providers in our target community
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SBIRT
2012
Completed Phase 2
~4990

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,471 Previous Clinical Trials
2,535,750 Total Patients Enrolled
47 Trials studying Depression
37,572 Patients Enrolled for Depression
National Institute of Mental Health (NIMH)NIH
2,869 Previous Clinical Trials
2,776,936 Total Patients Enrolled
687 Trials studying Depression
257,685 Patients Enrolled for Depression
Sidney Hankerson, MD, MBAPrincipal Investigator - Columbia University
Columbia University

Media Library

Referral as Usual Clinical Trial Eligibility Overview. Trial Name: NCT04524767 — N/A
Depression Research Study Groups: SBIRT, Referral As Usual
Depression Clinical Trial 2023: Referral as Usual Highlights & Side Effects. Trial Name: NCT04524767 — N/A
Referral as Usual 2023 Treatment Timeline for Medical Study. Trial Name: NCT04524767 — N/A
~107 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top